Peer-reviewedLicence not statedChinese Journal of Cancer Research30 Oct 2026

Comprehensive management of immune-related adverse events in the era of cancer immunotherapy: From reactive treatment to risk stratification and therapeutic coordination

Hanping Wang¹
Binhe Tian¹

¹Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Biomarker-guided immunotherapy in osteosarcoma: from immune microenvironment profiling to patient stratification and combination strategies.
Qingqing Li
Frontiers in medicine9 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Risk stratification for MDR/RR-TB: a comprehensive integrated patient-level analysis from TB programs and contemporary clinical trials.
Maria Garcia-Cremades, Jonathon R Campbell, Natasha Strydom +8
Nature communications22 Sep 2026Peer-reviewedCC BYFull textInfectious diseaseEurope PMCPMC
Care coordination through primary health care and network integration: the importance of ensuring comprehensive and integrated care in the Brazilian Unified National Health System
Patty Fidelis de Almeida, Simone Schenkman, Aylene Bousquat +2
Cadernos de Saúde Pública2 Nov 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthDOAJPMC
Inflammation After Transcatheter Aortic Valve Implantation: Mechanisms, Risk Stratification, and Therapeutic Implications
Mihail Celeski, Michele Marchetta, Emanuele Sammartini +9
Reviews in cardiovascular medicine1 Sep 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer.
Jii Bum Lee, Junwon Yang, Mauricio Chalita +19
Genome medicine6 Aug 2026Peer-reviewedCC BYFull textOncologyEurope PMCPMC

Cite

BibTeX

@article{wang2026comprehensive,
  title = {{Comprehensive management of immune-related adverse events in the era of cancer immunotherapy: From reactive treatment to risk stratification and therapeutic coordination}},
  author = {Hanping Wang and Binhe Tian},
  journal = {Chinese Journal of Cancer Research},
  year = {2026},
  month = oct,
  doi = {10.21147/j.issn.1000-9604.2026.05.01},
  url = {https://doi.org/10.21147/j.issn.1000-9604.2026.05.01},
}

RIS

TY  - JOUR
TI  - Comprehensive management of immune-related adverse events in the era of cancer immunotherapy: From reactive treatment to risk stratification and therapeutic coordination
AU  - Hanping Wang
AU  - Binhe Tian
PY  - 2026
DA  - 2026/10/30
JO  - Chinese Journal of Cancer Research
DO  - 10.21147/j.issn.1000-9604.2026.05.01
UR  - https://doi.org/10.21147/j.issn.1000-9604.2026.05.01
SN  - 1000-9604
SN  - 1993-0631
ER  -

Related

Cite